Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (191-200 of 407) with videos related to

Pageof 41
Sort By:
BMC Medicine|February 11, 2023
Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysisHorace C W Choi, Kathy Leung, Karen K L Chan, et al.
Plos One|October 25, 2011
7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?Yoon Hong Choi, Mark Jit, Nigel Gay, et al.
Plos Computational Biology|July 26, 2021
Projecting contact matrices in 177 geographical regions: An update and comparison with empirical data for the COVID-19 eraKiesha Prem, Kevin van Zandvoort, Petra Klepac, et al.
Journal of Medical Internet Research|March 22, 2021
Comparison of Public Responses to Containment Measures During the Initial Outbreak and Resurgence of COVID-19 in China: Infodemiology StudyXinyu Zhou, Yi Song, Hao Jiang, et al.
Vaccine|November 30, 2025
A systematised review of seasonal influenza case-fatality riskJohnny A N Filipe, Carlos K H Wong, Edwin van Leeuwen, et al.
Pharmacoeconomics|July 13, 2023
Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?Nancy J Devlin, Tianxin Pan, Mark Sculpher, et al.
The Lancet. Public Health|September 30, 2023
Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysisÉlodie Bénard, Mélanie Drolet, Jean-François Laprise, et al.
Plos Computational Biology|June 14, 2021
Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methodsBronner P Gonçalves, Simon R Procter, Sam Clifford, et al.
BMC Public Health|April 17, 2015
Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods studyIngeborg M van der Putten, Silvia M A A Evers, Rohan Deogaonkar, et al.
The Lancet Regional Health. Western Pacific|August 7, 2023
Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling studyMeng Gao, Shangying Hu, Xuelian Zhao, et al.
Pageof 41

Showing results (191-200 of 407) with videos related to

Sort By:
Pageof 41
BMC Medicine|February 11, 2023
Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysisHorace C W Choi, Kathy Leung, Karen K L Chan, et al.
Plos One|October 25, 2011
7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?Yoon Hong Choi, Mark Jit, Nigel Gay, et al.
Plos Computational Biology|July 26, 2021
Projecting contact matrices in 177 geographical regions: An update and comparison with empirical data for the COVID-19 eraKiesha Prem, Kevin van Zandvoort, Petra Klepac, et al.
Journal of Medical Internet Research|March 22, 2021
Comparison of Public Responses to Containment Measures During the Initial Outbreak and Resurgence of COVID-19 in China: Infodemiology StudyXinyu Zhou, Yi Song, Hao Jiang, et al.
Vaccine|November 30, 2025
A systematised review of seasonal influenza case-fatality riskJohnny A N Filipe, Carlos K H Wong, Edwin van Leeuwen, et al.
Pharmacoeconomics|July 13, 2023
Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?Nancy J Devlin, Tianxin Pan, Mark Sculpher, et al.
The Lancet. Public Health|September 30, 2023
Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysisÉlodie Bénard, Mélanie Drolet, Jean-François Laprise, et al.
Plos Computational Biology|June 14, 2021
Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methodsBronner P Gonçalves, Simon R Procter, Sam Clifford, et al.
BMC Public Health|April 17, 2015
Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods studyIngeborg M van der Putten, Silvia M A A Evers, Rohan Deogaonkar, et al.
The Lancet Regional Health. Western Pacific|August 7, 2023
Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling studyMeng Gao, Shangying Hu, Xuelian Zhao, et al.
Pageof 41